Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6.

Aldaz-Carroll L, Xiao Y, Whitbeck JC, de Leon MP, Lou H, Kim M, Yu J, Reinherz EL, Isaacs SN, Eisenberg RJ, Cohen GH.

J Virol. 2007 Aug;81(15):8131-9. Epub 2007 May 23.

2.

Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.

Hooper JW, Golden JW, Ferro AM, King AD.

Vaccine. 2007 Feb 26;25(10):1814-23. Epub 2006 Nov 27.

PMID:
17240007
3.

A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.

Xiao Y, Aldaz-Carroll L, Ortiz AM, Whitbeck JC, Alexander E, Lou H, Davis HL, Braciale TJ, Eisenberg RJ, Cohen GH, Isaacs SN.

Vaccine. 2007 Jan 26;25(7):1214-24. Epub 2006 Oct 17.

4.

Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen.

Sakhatskyy P, Wang S, Chou TH, Lu S.

Virology. 2006 Nov 25;355(2):164-74. Epub 2006 Aug 21.

5.

Subunit recombinant vaccine protects against monkeypox.

Heraud JM, Edghill-Smith Y, Ayala V, Kalisz I, Parrino J, Kalyanaraman VS, Manischewitz J, King LR, Hryniewicz A, Trindade CJ, Hassett M, Tsai WP, Venzon D, Nalca A, Vaccari M, Silvera P, Bray M, Graham BS, Golding H, Hooper JW, Franchini G.

J Immunol. 2006 Aug 15;177(4):2552-64.

6.

Adverse events associated with smallpox vaccination in the United States, January-October 2003.

Casey CG, Iskander JK, Roper MH, Mast EE, Wen XJ, Török TJ, Chapman LE, Swerdlow DL, Morgan J, Heffelfinger JD, Vitek C, Reef SE, Hasbrouck LM, Damon I, Neff L, Vellozzi C, McCauley M, Strikas RA, Mootrey G.

JAMA. 2005 Dec 7;294(21):2734-43.

PMID:
16333009
8.

Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.

Davies DH, McCausland MM, Valdez C, Huynh D, Hernandez JE, Mu Y, Hirst S, Villarreal L, Felgner PL, Crotty S.

J Virol. 2005 Sep;79(18):11724-33.

9.

Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine.

Wang S, Farfan-Arribas DJ, Shen S, Chou TH, Hirsch A, He F, Lu S.

Vaccine. 2006 May 22;24(21):4531-40. Epub 2005 Aug 18.

PMID:
16140431
10.

Interferon function is not required for recovery from a secondary poxvirus infection.

Panchanathan V, Chaudhri G, Karupiah G.

Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12921-6. Epub 2005 Aug 25.

11.

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus.

Edghill-Smith Y, Golding H, Manischewitz J, King LR, Scott D, Bray M, Nalca A, Hooper JW, Whitehouse CA, Schmitz JE, Reimann KA, Franchini G.

Nat Med. 2005 Jul;11(7):740-7. Epub 2005 Jun 12.

PMID:
15951823
12.

A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults.

Artenstein AW, Johnson C, Marbury TC, Morrison D, Blum PS, Kemp T, Nichols R, Balser JP, Currie M, Monath TP.

Vaccine. 2005 May 9;23(25):3301-9.

PMID:
15837236
13.
14.

ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.

Monath TP, Caldwell JR, Mundt W, Fusco J, Johnson CS, Buller M, Liu J, Gardner B, Downing G, Blum PS, Kemp T, Nichols R, Weltzin R.

Int J Infect Dis. 2004 Oct;8 Suppl 2:S31-44. Review.

15.
16.

Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.

Kennedy JS, Frey SE, Yan L, Rothman AL, Cruz J, Newman FK, Orphin L, Belshe RB, Ennis FA.

J Infect Dis. 2004 Oct 1;190(7):1286-94. Epub 2004 Aug 30.

PMID:
15346340
17.
18.

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.

Wang S, Heilman D, Liu F, Giehl T, Joshi S, Huang X, Chou TH, Goguen J, Lu S.

Vaccine. 2004 Sep 3;22(25-26):3348-57.

PMID:
15308359
19.

Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.

Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ichou MA, Steffen SE, Schmaljohn CS, Schmaljohn AL, Jahrling PB.

J Virol. 2004 May;78(9):4433-43.

20.

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.

Wyatt LS, Earl PL, Eller LA, Moss B.

Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4590-5. Epub 2004 Mar 11.

Supplemental Content

Support Center